Siegfried Reich, EVP & Chief Scientific Officer at Turning Point Therapeutics, Inc. (TPTX), sold 397 shares at $36.30 ($14K) on 2022-02-09, disclosed to the SEC on 2022-02-11.
Open-market sale of $14k TPTX by EVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SGXP | SELL | 2008-07-16 | $2K | — | Filing → |
| SGXP | SELL | 2008-06-17 | $1K | — | Filing → |
| SGXP | SELL | 2008-05-15 | $1K | — | Filing → |